From: HRG C633T polymorphism and risk of gestational hypertensive disorders: a pilot study
Homozygous C/C | Heterozygous C/T | Homozygous T/T | ||
---|---|---|---|---|
Genotype distribution | 141/292 (48.3%) | 116/292 (39.7%) | 35/292 (12%) | |
Maternal age, yrs | 31 (IQR = 7) | 32 (IQR = 6) | 33 (IQR = 7) | p = 0.346 |
Maternal BMI, kg/m2 | 24 (IQR = 5.92) | 24.46 (IQR = 5.58) | 22.86 (IQR = 4.86) | p = 0.676 |
Primiparity | 65/141 (45.5%) | 54/116 (46.6%) | 20/35 (57.1%) | p = 0.483 |
Nicotine use | 12/139 (8.6%) | 8/112 (7.1%) | 2/34 (5.9%) | p = 0.829 |
Gestational length, weeks | 40 (IQR = 1) | 39 (IQR = 2) | 40 (IQR = 1) | p = 0.325 |
Male Infant Gender | 81/140 (57.9%) | 57/115 (49.6%) | 20/35 (57.1%) | p = 0.394 |
Birthweight, gr | 3615 (IQR = 800) | 3665 (IQR = 685) | 3420 (IQR = 945) | p = 0.394 |
Birthlength, cm | 51 (IQR = 3) | 51 (IQR = 2) | 50 (IQR = 4) | p = 0.562 |